The inconsistency in these findings may be attributed to differences in disease populations (T2DM with MCI or MCI), sample source (whole blood or plasma) and detection method of tau protein (Western blot or enzyme-linked immunosorbent assay). The gene discussed is MAPT; the disease is type 2 diabetes mellitus.